Agenus to Participate in September Investor Conferences

On August 28, 2023 Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, reported that Dr. Garo Armen, Chairman and CEO, will participate in the following upcoming investor conferences (Press release, Agenus, AUG 28, 2023, View Source [SID1234634731]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Wells Fargo Healthcare Conference – Fireside chat presentation will be held in-person on Thursday, September 7th, 2023, at 11:00 a.m. ET in Boston, MA. A live webcast and replay will be accessible on the company’s website at View Source

Baird 2023 Global Healthcare Conference– Fireside chat presentation will be held in person on Tuesday, September 12th, 2023, at 4:20 p.m. ET, in New York, NY. This content is for Baird clients attending the conference. There will not be a webcast replay.

HC Wainwright 25th Annual Global Investment Conference – Fireside chat presentation will be held in-person on Wednesday, September 13th, 2023, at 11:00 a.m. ET, in New York, NY. A live webcast and replay will be accessible on the company’s website at View Source